Austria's Borealis, AnQore launch world's first circular acrylonitrile
Borvida B-propylene is part of the broader Borvida portfolio of renewable and circular base chemicals. Offering the same properties and performance as conventional base chemicals, they have a lower carbon footprint and also support the shift away from fossil feedstocks. Renewable content is tracked through the value chain using a Chain of Custody model, based on the Mass Balance approach. This means circular content can be traced and verified from source to final product.
Borealis has partnered with AnQore to produce the world's first circular, mass-balanced acrylonitrile (ACN) using Borvida B-propylene, a sustainable ISCC PLUS-certified feedstock. The initiative supports reduced carbon emissionsâ€'up to 90 per cent lower than conventional ACNâ€'without compromising performance, enabling more sustainable products across multiple industries.
Econitrile-MB produced using Borvida B-propylene from Borealis and sustainable ammonia has been in production for several years, offering end users a broader of sustainable solutions.
Econitrile gives producers of ABS, acrylamide, carbon fiber, acrylic fiber, nitrile rubber, surfactants, and many other advanced materials a way to boost the sustainability of their products. With a carbon footprint up to 90% lower per kilogram than regular acrylonitrile, Econitrile offers a significantly more sustainable alternative without compromising on performance at all.
'At AnQore, we're striving to make the value chains for our specialist chemicals more sustainable, and that starts with the raw materials,' says Sjoerd Zuidema, CEO of AnQore . 'We're proud that, thanks to our partnership with Borealis, we're able to offer the world's first circular, mass-balanced acrylonitrile, and support our customers in making more sustainable products.'
This partnership shows how Borealis is putting its We4Customers strategy into action by enabling customers like AnQore to access high-quality circular materials, backed by a secure supply and the flexibility and support needed to respond to changing market needs and regulations.
'This partnership shows that by working together across the value chain, we can unlock the value of waste,' says Thomas Van De Velde, Borealis Senior Vice President Base Chemicals . 'With AnQore, we're developing innovative, high-performance solutions that support customers' sustainability goals and help them prepare for future sustainable transformation.'
AnQore is a trusted European producer of acrylonitrile and other key chemical building blocks, based at the Chemelot Chemical Park in Geleen, the Netherlands. AnQore focuses on delivering safe, secure, and sustainable solutions that help its customers stay ahead, whether in water treatment, consumer goods, or high-performance applications like automotive and electronics. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged.
Fibre2Fashion News Desk (RM)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
2 minutes ago
- Economic Times
Tata Motors seeks to expand revenues, access new technologies with $4.5 bln Iveco deal
Agencies Tata Motors acquires Iveco' Tata Motors' record $4.5 billion offer to buy Iveco's trucks and bus business will expand the commercial vehicle maker's revenues beyond India and give it access to the Italian company's future technologies including electrification. The all-cash deal marks the biggest transaction for Mumbai-based Tata Motors, which made its last big purchase in 2008 when it acquired Jaguar Land Rover from Ford Motor Co for $2.3 billion. Shares of Tata Motors fell as much as 2.4% on Thursday morning, reflecting concerns around possible high levels of debt and equity the truckmaker will need to raise, but recouped those losses and were little changed as of 0826 GMT. Iveco and Tata's commercial vehicles business will have combined revenues of about 22 billion euros ($25 billion), with half coming from Europe, 35% from India and the remainder from the Americas, the Indian automaker said in a statement to the stock exchanges late on Wednesday. This is "the next logical step" after Tata Motors' demerger of its three businesses - commercial vehicles, passenger cars and electric vehicles, the company's chairman N Chandrasekaran said in the statement. "(This) will allow the combined group to compete on a truly global basis with two strategic home markets in India and Europe," he read: Tata Motors to drive Iveco's CV business for $4.4 billion, the group's biggest cross border M&A since Corus The deal, expected to close by April 2026, will give Tata Motors' trucks and bus business a foothold in the European market, where it will go head-on with Volvo and Daimler. Tata already has a manufacturing and sales presence in Europe through Jaguar Land Rover, which has been a cash cow for the company but is increasingly facing pressure in its major markets of China and the United States. It will also get access to Iveco's future technologies including electrification as well as its talent pool.
NDTV
14 minutes ago
- NDTV
Trump Tariff Deadline Looms Large: Trade Deals US Has Announced So Far
New York: The clock is ticking closer to US President Donald Trump's latest tariff deadline of August 1. And while several more deals — or at least frameworks for deals — have been reached since his last tariff deadline of July 9 came and went, trade talks with many countries are still in flux. Trump unveiled sweeping import taxes on goods coming into the US from nearly every country back in April. That included heightened so-called reciprocal rates for certain countries, the bulk of which have since been postponed twice. The first 90-day pause arrived in an apparent effort to quell global market panic and facilitate country-by-country negotiations, with the Trump administration at one point setting a lofty goal of reaching 90 trade deals in 90 days. But three months later, only two deals emerged: with the UK and Vietnam. A separate 'framework' for a deal was hashed out with China. And by early July, Trump began sending warning letters that higher tariffs would be imposed against dozens of countries on August 1. Since then, the US has announced more trade frameworks. But key details remain sparse — or not immediately captured in writing. Here's what we know about the agreements so far, in the order of those most recently announced. The US president said he reached an agreement with Seoul on July 30 that would impose a 15% tariff on goods from South Korea. The countries have also agreed for South Korea to buy $100 billion in energy resources from the US and for South Korea to give to the US $350 billion for 'investments owned and controlled by the United States, and selected by myself, as president,' Trump said. The US and the EU announced a trade framework that imposes 15% tariffs on most European goods, warding off Trump's most recent threat of 30% if no deal had been reached by August 1. But some key details require more work. The headline of the agreement, unveiled July 27, is that the 15% tariff rate will apply to 70% of European goods brought into the US, with the EU later confirming that that rate applies to pharmaceuticals, semiconductors, and car and car parts. But the remaining 30% of those imports is still open for negotiations. European Commission President Ursula von der Leyen said that both sides had agreed to zero tariffs for a range of 'strategic' goods. Meanwhile, Trump pointed to heightened investments from European companies in the US — including what Trump said was $750 billion (638 billion euros) worth of natural gas, oil and nuclear fuel over three years, as well as an additional $600 billion (511 billion euros) under a political commitment that isn't legally binding, officials said. On July 22, Trump announced a trade framework to impose 15% tariffs on Japan — down from his previously-threatened rate of 25%. The US president also said Japan would invest $550 billion into the US and would 'open' its economy to American autos and rice. The newly-agreed on 15% tariff rate also applies to Japanese cars — marking a welcome relief for automakers like Toyota Motor Corp and Honda, which, like other automakers, have faced a 25% levy on key parts and finished vehicles going into the US since earlier this year. But car companies in other countries, including US competitors, worry that this could put them at a disadvantage. Shortly after a July 22 meeting with Philippine President Ferdinand Marcos Jr, Trump announced that he would lower his upcoming tariffs on imports from the country to 19% — down just 1% from his previous threat of 20%. In return, Trump said on Truth Social, the US would not pay tariffs on American goods it shipped to the Philippines. But additional details remained unclear. Marcos said his country was considering options such as having an open market without tariffs for US automobiles, but emphasized details were still left to be worked out. On July 15, Trump again took to social media to announce that he's agreed to lower his planned tariffs on Indonesian goods to 19% — down from a previously-threatened levy of 32% — while American goods sent to the Southeast Asian country will face no tariffs. A fact sheet from the White House later confirmed that 'over 99% of US products' exported to Indonesia would be sent duty-free. Indonesian President Prabowo Subianto said he will continue to negotiate with Trump, in hopes of further lowering the coming US tariffs. On July 2, Trump announced a trade deal with Vietnam that he said would allow US goods to enter the country duty-free. Vietnamese exports to the US, by contrast, would face a 20% levy. That's less than half the 46% 'reciprocal' rate Trump proposed for Vietnamese goods back in April. But in addition to the new 20% tariff rate, Trump said the US would impose a 40% tax on 'transshipping'' — targeting goods from another country that stop in Vietnam on their way to the United States. Washington complains that Chinese goods have been dodging higher US tariffs by transiting through Vietnam. On May 8, Trump agreed to cut tariffs on British autos, steel, and aluminum, among other trade pledges — while the UK promised to reduce levies on US products like olive oil, wine, and sports equipment. The deal was announced in grandiose terms by both countries, but some key details remained unknown for weeks. When the deal was announced, for example, the British government notably said that the US agreed to exempt the UK from its then-universal 25% duties on foreign steel and aluminum, which would have effectively allowed both metals from the country to come into the US duty-free. But the timing for when those cuts would actually take effect stayed up in the air for almost a month. It wasn't until early June, when Trump hiked his steel and aluminum tariffs to a punishing 50% worldwide, that the US acknowledged it was time to implement the agreement. And even then, US tariffs on British steel and aluminum did not go to zero. The UK was the only country spared from Trump's new 50% levies, but it still faces 25% import taxes on the metals. At its peak, Trump's new tariffs on Chinese goods totaled 145%, and China's countertariffs on American products reached 125%. But on May 12, the countries agreed to their own 90-day truce to roll back those levies to 30% and 10%, respectively. And in June, details began trickling in about a tentative trade agreement. US Treasury Secretary Scott Bessent said that China had agreed to make it easier for American firms to acquire Chinese magnets and rare earth minerals critical for manufacturing and microchip production. Meanwhile, the Chinese Commerce Ministry said that the US would 'lift a series of restrictive measures it had imposed on China." Other key details of the deal remain murky — including the timing of implementation for these terms. On July 29, China's top trade official said the two sides had agreed to work on extending an August 12 deadline for new tariffs on each other, following a two-day trade meeting in Stockholm. The US side said extension plans were discussed, but not decided.
Time of India
30 minutes ago
- Time of India
Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say
AI-generated image India's pharmaceutical sector has given its insights into US President Donald Trump's announcement of a 25 per cent tariff on all Indian imports starting August 1, warning that the move could significantly disrupt American healthcare rather than weaken Indian industry. While uncertainty remains about whether pharmaceuticals will fall under the new tariff list- given Trump's April declaration that excluded essential drugs- the reaction from Indian pharma stakeholders has been swift and pointed. 'He is trying to kill the market of the Indian economy, but it is not going to happen,' said Dilip Kumar, Chairman of the Chamber of Commerce's Medical Tourism wing, speaking to ANI. 'We are exporters, especially of medical equipment, pharmaceuticals, and disposables, which mostly come from India. The American market is dependent upon Indian and Chinese markets," he added. Kumar also said that, 'India won't be impacted, as we will go by the route of exporting to European countries. We can survive in the toughest times and bounce back." Also read: 25% tariff on India; 'dead economies' jibe, trade deal with Pakistan & more – Key points Echoing these sentiments, Pharmaceuticals Export Promotion Council of India (Pharmexcil) Chairman Namit Joshi issued a statement through PTI highlighting India's indispensable role in the US drug supply chain. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo 'India has long been a cornerstone of the global supply chain for affordable, high-quality medicines, particularly in the generic drug market, where it supplies nearly 47 per cent of the pharmaceutical needs of the US,' said Joshi. 'Indian pharmaceutical companies play a vital role in ensuring the affordability and availability of essential medications, including life-saving oncology drugs, antibiotics, and chronic disease treatments,' he added. Joshi warned that the immediate fallout of the tariff move would be rising drug prices and possible shortages in the US. 'Any disruption to this supply chain will inevitably lead to shortages and escalating prices, ultimately harming US consumers and healthcare systems.' He noted that while the short-term impact would be painful, the long-term risks were even more serious. 'The long-term impact will be even more severe. The US market, heavily reliant on India for Active Pharmaceutical Ingredients (APIs) and low-cost generics, faces a daunting challenge in finding alternative sources that can match the scale, quality, and affordability that India offers," Joshi said continuing his insights. Efforts to transition manufacturing and API production to other countries or domestic facilities in the US could take 'at least 3–5 years before meaningful capacity can be established,' he cautioned. Despite the uncertainty, Pharmexcil said it remained committed to working with stakeholders to maintain India's role as a reliable supplier of affordable medicines. 'We continue to engage with policymakers to emphasise the importance of affordable access to medicines and the indispensable role Indian pharmaceutical companies play in meeting the growing global demand for essential drugs,' Joshi said. Stay informed with the latest business news, updates on bank holidays and public holidays . Discover stories of India's leading eco-innovators at Ecopreneur Honours 2025
